Evaluating latency reactivation synergies between the bromodomain inhibitor iBET-151 and the SMAC mimetic AZD5582 in SIV-infected macaques on ART

Evaluating latency reactivation synergies between the bromodomain inhibitor iBET-151 and the SMAC mimetic AZD5582 in SIV-infected macaques on ART

Bibliographic Details
Main Authors: A.A. Okoye, Y. Fukazawa, B.E. Randall, R. Lum, B. Varco-Merth, S.D. Falcinelli, J. Smedley, R. Dunham, J.D. Lifson, L.J. Picker
Format: Article
Language:English
Published: Elsevier 2019-12-01
Series:Journal of Virus Eradication
Online Access:http://www.sciencedirect.com/science/article/pii/S2055664020301254
id doaj-75d540f91fcc454bae40f65d4bf589ac
record_format Article
spelling doaj-75d540f91fcc454bae40f65d4bf589ac2021-05-05T04:04:31ZengElsevierJournal of Virus Eradication2055-66402019-12-01521Evaluating latency reactivation synergies between the bromodomain inhibitor iBET-151 and the SMAC mimetic AZD5582 in SIV-infected macaques on ARTA.A. Okoye0Y. Fukazawa1B.E. Randall2R. Lum3B. Varco-Merth4S.D. Falcinelli5J. Smedley6R. Dunham7J.D. Lifson8L.J. Picker9Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Or, USAVaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Or, USAVaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Or, USAVaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Or, USAVaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Or, USAUNC HIV Cure Center, University of North Carolina at Chapel Hill and HIV Drug Discovery, ViiV Healthcare, Research Triangle Park, Nc, USAVaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Or, USAUNC HIV Cure Center, University of North Carolina at Chapel Hill and HIV Drug Discovery, ViiV Healthcare, Research Triangle Park, Nc, USAAIDS and Cancer Virus Program, Frederick National Laboratory, Frederick, Md, USAVaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Or, USAhttp://www.sciencedirect.com/science/article/pii/S2055664020301254
collection DOAJ
language English
format Article
sources DOAJ
author A.A. Okoye
Y. Fukazawa
B.E. Randall
R. Lum
B. Varco-Merth
S.D. Falcinelli
J. Smedley
R. Dunham
J.D. Lifson
L.J. Picker
spellingShingle A.A. Okoye
Y. Fukazawa
B.E. Randall
R. Lum
B. Varco-Merth
S.D. Falcinelli
J. Smedley
R. Dunham
J.D. Lifson
L.J. Picker
Evaluating latency reactivation synergies between the bromodomain inhibitor iBET-151 and the SMAC mimetic AZD5582 in SIV-infected macaques on ART
Journal of Virus Eradication
author_facet A.A. Okoye
Y. Fukazawa
B.E. Randall
R. Lum
B. Varco-Merth
S.D. Falcinelli
J. Smedley
R. Dunham
J.D. Lifson
L.J. Picker
author_sort A.A. Okoye
title Evaluating latency reactivation synergies between the bromodomain inhibitor iBET-151 and the SMAC mimetic AZD5582 in SIV-infected macaques on ART
title_short Evaluating latency reactivation synergies between the bromodomain inhibitor iBET-151 and the SMAC mimetic AZD5582 in SIV-infected macaques on ART
title_full Evaluating latency reactivation synergies between the bromodomain inhibitor iBET-151 and the SMAC mimetic AZD5582 in SIV-infected macaques on ART
title_fullStr Evaluating latency reactivation synergies between the bromodomain inhibitor iBET-151 and the SMAC mimetic AZD5582 in SIV-infected macaques on ART
title_full_unstemmed Evaluating latency reactivation synergies between the bromodomain inhibitor iBET-151 and the SMAC mimetic AZD5582 in SIV-infected macaques on ART
title_sort evaluating latency reactivation synergies between the bromodomain inhibitor ibet-151 and the smac mimetic azd5582 in siv-infected macaques on art
publisher Elsevier
series Journal of Virus Eradication
issn 2055-6640
publishDate 2019-12-01
url http://www.sciencedirect.com/science/article/pii/S2055664020301254
work_keys_str_mv AT aaokoye evaluatinglatencyreactivationsynergiesbetweenthebromodomaininhibitoribet151andthesmacmimeticazd5582insivinfectedmacaquesonart
AT yfukazawa evaluatinglatencyreactivationsynergiesbetweenthebromodomaininhibitoribet151andthesmacmimeticazd5582insivinfectedmacaquesonart
AT berandall evaluatinglatencyreactivationsynergiesbetweenthebromodomaininhibitoribet151andthesmacmimeticazd5582insivinfectedmacaquesonart
AT rlum evaluatinglatencyreactivationsynergiesbetweenthebromodomaininhibitoribet151andthesmacmimeticazd5582insivinfectedmacaquesonart
AT bvarcomerth evaluatinglatencyreactivationsynergiesbetweenthebromodomaininhibitoribet151andthesmacmimeticazd5582insivinfectedmacaquesonart
AT sdfalcinelli evaluatinglatencyreactivationsynergiesbetweenthebromodomaininhibitoribet151andthesmacmimeticazd5582insivinfectedmacaquesonart
AT jsmedley evaluatinglatencyreactivationsynergiesbetweenthebromodomaininhibitoribet151andthesmacmimeticazd5582insivinfectedmacaquesonart
AT rdunham evaluatinglatencyreactivationsynergiesbetweenthebromodomaininhibitoribet151andthesmacmimeticazd5582insivinfectedmacaquesonart
AT jdlifson evaluatinglatencyreactivationsynergiesbetweenthebromodomaininhibitoribet151andthesmacmimeticazd5582insivinfectedmacaquesonart
AT ljpicker evaluatinglatencyreactivationsynergiesbetweenthebromodomaininhibitoribet151andthesmacmimeticazd5582insivinfectedmacaquesonart
_version_ 1721475828561215488

Similar Items